Experienced quality and regulatory leader with over 16 years of hands-on expertise across medical devices, diagnostics, and digital health platforms. As co-founder of Ehmet Health, he oversees compliance and validation strategies for advanced imaging and radiotherapy systems, with expertise spanning ISO 13485, FDA 21 CFR Part 820, 510(k)/De Novo submissions, and clinical trial support. Daniel combines technical depth with practical leadership to ensure regulatory readiness and operational excellence from early development through commercial integration.